-
Product Insights
Gallbladder Cancer – Drugs In Development, 2023
Global Markets Direct’s, ‘Gallbladder Cancer - Drugs In Development, 2023’, provides an overview of the Gallbladder Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Gallbladder Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Company Insights
The Emirates Group – Digital Transformation Strategies
Emirates Digital Transformation Strategies Overview Emirates is leveraging several emerging technologies as a part of its digital transformation strategies. The annual ICT spending of Emirates was estimated at $819 million in 2023. A major share of this spending is earmarked for acquiring software, network and communications, and hardware from vendors. The Emirates Group (Emirates Group) provides domestic, regional, and international air transportation services. The company’s other operations include wholesale and retail of consumer goods, food and beverage sales, and hotel...
-
Product Insights
Drug Eluting Stents (DES) Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Drug Eluting Stents (DES) Pipeline Market Report Overview Drug eluting stents (DES) release drugs locally and can be coated with a polymeric material. The Drug Eluting Stents (DES) pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Eganelisib in Ovarian Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Eganelisib in Ovarian Cancer Drug Details: IPI-549 is under development for the treatment of solid...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Eganelisib in Metastatic Ovarian Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Eganelisib in Metastatic Ovarian Cancer Drug Details: IPI-549 is under development for the treatment of...
-
Product Insights
NewNet Present Value Model: Infinity Pharmaceuticals Inc’s IPI-549 + Opdivo
Empower your strategies with our Net Present Value Model: Infinity Pharmaceuticals Inc's IPI-549 + Opdivo report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Eganelisib in Metastatic Transitional (Urothelial) Tract Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Eganelisib in Metastatic Transitional (Urothelial) Tract Cancer Drug Details: IPI-549 is under development for the...
-
Product Insights
San Jose Lithium-Tin Project
The San Jose Lithium-Tin Project is a lithium project in Spain. It is currently at the feasibility stage. Empower your strategies with our San Jose Lithium-Tin Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance....